These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Arthritis due to Paracoccus yeei]. Coiffier G; Gougeon A; Albert JD; Le Bars H Med Mal Infect; 2013 Jun; 43(6):254-5. PubMed ID: 23751881 [No Abstract] [Full Text] [Related]
5. [Therapeutic approach to elderly patients with rheumatoid arthritis]. Beccerica E Clin Ter; 1987 Aug; 122(4):289-98. PubMed ID: 2973390 [No Abstract] [Full Text] [Related]
6. [Limits of immunosuppressive therapy]. Götz H Munch Med Wochenschr; 1971 Jun; 113(23):906. PubMed ID: 4931698 [No Abstract] [Full Text] [Related]
7. Tuberculosis and immune thrombocytopenia. Madkaikar M; Ghosh K; Jijina F; Gupta M; Rajpurkar M; Mohanty D Haematologica; 2002 Aug; 87(8):ELT38. PubMed ID: 12161383 [No Abstract] [Full Text] [Related]
8. [Ocular zona and herpes in patients under immunosuppressive agents. Apropos of 9 cases]. Lagoutte F; Campagne JC; Monroy J; Le Rebeller MJ Bull Soc Ophtalmol Fr; 1980 Mar; 80(3):289-90. PubMed ID: 6965894 [No Abstract] [Full Text] [Related]
9. The treatment of SLE: the case of conservative management. Hughes GR Clin Rheum Dis; 1982 Apr; 8(1):299-313. PubMed ID: 6214364 [No Abstract] [Full Text] [Related]
10. [Corticosteroids and diabetes mellitus]. Gagliardi L; Le Jeunne C Presse Med; 2012 Apr; 41(4):393-9. PubMed ID: 22361026 [TBL] [Abstract][Full Text] [Related]
11. [Bullous pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]. Bernard P; Bedane C; Prost C; Ingen-Housz-Oro S; Joly P; Ann Dermatol Venereol; 2011 Mar; 138(3):247-51. PubMed ID: 21397154 [No Abstract] [Full Text] [Related]
12. Mycobacterium chelonae infection in a patient being treated with adalimumab. Conejero R; Ara M; Lorda M; Rivera I Actas Dermosifiliogr; 2012 Jan; 103(1):69-71. PubMed ID: 22464598 [No Abstract] [Full Text] [Related]
13. [Cardiovascular risks of corticosteroids]. Szwebel TA; Le Jeunne C Presse Med; 2012 Apr; 41(4):384-92. PubMed ID: 22361027 [TBL] [Abstract][Full Text] [Related]
14. L38. How to treat primary vasculitis of the central nervous system. Pagnoux C; de Boysson H Presse Med; 2013 Apr; 42(4 Pt 2):605-7. PubMed ID: 23465297 [No Abstract] [Full Text] [Related]
15. [Corticotherapy: a useful update]. Le Jeunne C Presse Med; 2012 Apr; 41(4):368-9. PubMed ID: 22366445 [No Abstract] [Full Text] [Related]
16. [Pemphigus. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]. Joly P; Bernard P; Bedane C; Prost C; Ingen-Housz-Oro S; Ann Dermatol Venereol; 2011 Mar; 138(3):252-8. PubMed ID: 21397155 [No Abstract] [Full Text] [Related]
17. [Drug therapy of chronic juvenile arthritis]. Tulzer W Padiatr Padol; 1987; 22(2):199-210. PubMed ID: 3614954 [TBL] [Abstract][Full Text] [Related]
18. Factors contributing to severity of herpes zoster in children. Bacon GE; Oliver WJ; Shapiro BA J Pediatr; 1965 Nov; 67(5):763-71. PubMed ID: 5845441 [No Abstract] [Full Text] [Related]
19. [Development and long term prognosis of lupus erythematosus (apropos of 124 cases)]. Godeau P; Betourne C; Piette JC; Herreman G; Wechsler B; Levy R Ann Med Interne (Paris); 1977 Jan; 128(1):17-30. PubMed ID: 855968 [TBL] [Abstract][Full Text] [Related]
20. Clinical immunotoxicity of antirheumatic drugs. Bálint G; Gergely P Inflamm Res; 1996 Dec; 45 Suppl 2():S91-5. PubMed ID: 8988409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]